TIDMADAM
RNS Number : 0654S
Adamas Finance Asia Limited
21 June 2018
21 June 2018
ADAMAS FINANCE ASIA LIMITED
("ADAM" or the "Company")
FINAL RESULTS FOR THE YEARED 31 DECEMBER 2017
Adamas Finance Asia Limited (AIM: ADAM), a London quoted
pan-Asian diversified investment vehicle, is pleased to announce
the publication of its Final Results for the year ended 31 December
2017.
During 2017, the Company underwent a change of its Investment
Manager, investment strategy and a revision of its portfolio
holdings including new investments as well as disposals. The net
result has been to report a net profit of US$11.7 million and an
increase in NAV of US$15.8 million to US$93.6 million.
Highlights of the year
Performance update
-- NAV increase of US$15.8m to US$93.6m (2016: US$77.8m)
-- Net profit of US$11.7m (2016: loss of US$37.2m)
-- The gain reflects a net increase in fair value movements in the portfolio of US$19.6m
-- This included a realised loss on investment disposals of
US$14.3m and unrealised gains on fair value changes of US$33.9m
-- Year-end cash of US$13.2m (2016: US$1.3m)
-- NAV per Share of US$1.22 (2016: US$0.40)
Significant events post year end affecting Portfolio
valuations
-- In April 2018 the Company announced that its interest in a
substantial part of the legacy portfolio is being exchanged for a
Convertible Bond in a Hong Kong based food and beverage
business
-- A notable new investment was made in March 2018 in DocDoc, a
leading online Asian patient empowerment company
-- The Company announced the renegotiation of its agreement to
dispose of its interest in Global Pharm resulting in a loss on
disposal of US$14.3 million
Commenting on ADAM's final results, John Croft, Chairman,
said:
"I am very pleased to be able to report that significant
progress has been made in reshaping our portfolio in line with our
strategy, most significantly with the agreed disposal of a number
of our largest assets and thereby bringing cash into the vehicle
that will be available for reinvestment in the exciting pipeline of
investments on which our Investment Manager is working.
"Overall, I am confident that 2018 will be a year of further
progress both with disposals and new investments as we move towards
a predominantly income generating portfolio which will allow us to
make regular dividend distributions to our shareholders."
Enquiries:
Adamas Finance Asia Limited
John Croft +44 (0) 1825 830587
WH Ireland Limited - Nominated
Adviser
Tim Feather +44 (0) 113 394 6600
James Sinclair-Ford
Shard Capital Partners LLP -
Broker
Philip Pooley +44 (0) 20 7186 9967
Buchanan - Financial PR
Charles Ryland +44 (0) 20 7466 5000
Henry Wilson
The information contained within this announcement is deemed by
the Company to constitute inside information under the Market Abuse
Regulation (EU) No. 596/2014.
About Adamas Finance Asia
ADAM is a London quoted investment company focusing on
delivering long-term income and capital growth to shareholders
through a diverse portfolio of pan-Asian investments. It aims to
provide uncorrelated returns through a combination of capital
growth and dividend income from a broad spectrum of national
geographies and asset classes.
The Company's Investment Manager, Harmony Capital, which has a
dedicated team with real Asian expertise, is focused on the
strategy of creating income and capital growth. Harmony Capital is
sourcing predominantly private opportunities and has created a
strong pipeline of income generating assets which include potential
investments in fintech, healthcare, property, mining,
pharmaceuticals and telecoms across Asia.
Chairman's Statement
Since the beginning of 2017, I am very pleased to report that
significant progress has been made in reshaping our portfolio in
line with our new strategy, most significantly with agreeing the
disposal of a number of our largest assets and thereby bringing
cash into the Company that will be available for reinvestment in
the exciting pipeline of investments which our Investment Manager,
Harmony Capital Investors Limited ("Harmony Capital"), has already
identified.
Whilst some of the agreed disposals have resulted in write downs
in value directly impacting our income statement, they will
nevertheless generate much needed cash for reinvestment, which your
Board believes is a better option than retaining interests in
assets which may take many years to deliver acceptable returns.
In contrast, the increase in our holding in Hong Kong Mining
("HKMH") announced in December 2017 resulted in a significant
increase in the audited carrying value of that investment. The
increase in shareholding in HKMH is a result of the completion of
the enforcement of a share pledge following the suspension of
HKMH's IPO process as announced in January 2016.
A summary of each of the major investments in the asset
portfolio is provided in the report which follows.
The net effect of the changes described above is that the
Company is reporting a net profit for 2017 amounting to US$11.7
million, principally comprising a realised loss on investment
disposals of US$14.3 million and unrealised gains on fair value
changes of US$33.9 million, resulting in an increase in the NAV of
US$15.8 million to US$93.6 million.
Since the end of 2017 we have also been able to make further
announcements regarding the disposal of other legacy assets which
were identified for disposal, as well as our first new investment
since the appointment of Harmony Capital as Investment Manager.
The most significant disposal was that of the Company's
interests in a significant proportion of its legacy portfolio
announced in April 2018, comprising China iEducation Holdings
Limited, CPE Finance Limited, CPE Growth Capital Limited, CPE TMT
Holdings Limited and the Fortel Loan. In consideration for the
disposal, the Company will be issued with an interest bearing
US$26.5 million Convertible Bond by the Issuer, which, upon
completion of a restructuring, will be the controlling shareholder
of a long-established and well-known Hong Kong-based food and
beverage business, primarily operating in high-end Chinese
restaurants. A further announcement will be made in due course.
The previously announced disposal of our interest in Global
Pharm Holdings Group Inc. did not complete as originally planned.
Revised terms for the disposal were announced on 15 June 2018. The
Company will still receive a cash injection of US$15.6 million,
through US$3 million in consideration and a subscription for
US$12.6 million in new equity. As a result, the results reflect a
balance sheet write down of US$14.3 million in respect of the
Global Pharm interest.
Now that many of the legacy assets have been either
restructured, sold or are in the process of being sold, Harmony
Capital is able to focus its energies more fully on new
investments. They are working on a strong deal pipeline and I
anticipate we will be announcing more new investments in due
course.
Overall, 2017 saw major progress being achieved particularly
with reshaping the portfolio and I am confident that 2018 will be a
year of further progress both with disposals and new investments as
we move towards a predominantly income generating portfolio. This
will enable us ultimately to make regular dividend distributions to
our shareholders.
The principal assets held by the Company at the year-end
were:
Portfolio at 31 December 2017
Principal Assets Effective Instrument type Valuation
Interest as at 31 December
2017
US$ million
CPE Legacy Portfolio (Fortel
Loan/China iEducation Interest bearing
etc.) - loan/Equity 26.5
Hong Kong Mining Holdings
Limited 79.26% Structured equity 39.4
Meize Energy Industrial Redeemable convertible
Holdings Ltd 7.9% preference shares 8.2
Global Pharm Holdings
Group Inc. - Receivable 3.0
GCCF/Other 3.3
Cash 13.2
--------------------------------- ---------- -------------------- ------------------------
Total net asset value 93.6
--------------------------------- ---------- -------------------- ------------------------
Global Pharm Holdings Group Inc. ("Global Pharm") In September
2017 the Company announced the planned disposal of the Group's
interest in Global Pharm for a cash consideration of US$15.6
million to Fortune Insight Limited ("Fortune"), a special purpose
vehicle (SPV) set up specifically to acquire the interest in Global
Pharm and other unrelated assets. However, settlement of the
transaction was not completed on time and the terms of the disposal
were renegotiated. Under the new terms announced on 15 June 2018,
the Company is entitled to receive US$3.0 million in cash in
settlement of the disposal, and in addition Fortune will subscribe
to new shares to the value of US$12.6 million. The Company has
therefore incurred a balance sheet write-down of approximately
US$14.3 million in the results for the year.
CPE Legacy Portfolio (Fortel Loan/China iEducation etc.) Post
year end, the Company announced the disposal of its interests in a
significant portion of its legacy portfolio, comprising China
iEducation Holdings Limited, CPE Finance Limited, CPE Growth
Capital Limited, CPE TMT Holdings Limited and the Fortel Loan. In
consideration for these disposals, the Company will be issued with
an interest bearing Convertible Bond by the Issuer, which, upon
completion of a restructuring, will be the controlling shareholder
of a long-established and well-known Hong Kong-based food and
beverage business primarily operating in high-end Chinese
restaurants.
The Issuer is a newly incorporated special purpose vehicle, set
up as part of a wider concurrent restructuring exercise being
undertaken by Chinese Food and Beverage Group Limited ("CFBG"),
which is a Hong Kong listed restaurant, food and beverage business.
Prior to completion of the restructuring, CFBG's subsidiaries owned
a substantial interest in the assets and business comprising the
Fook Lam Moon restaurant business, being the Hong Kong restaurants
in Wanchai and Kowloon (including the freehold interest in those
properties), related intellectual property and management companies
and certain other real estate holdings in Hong Kong.
Hong Kong Mining Holdings Limited ("HKMH") HKMH is a natural
resources company whose primary asset is a large dolomite magnesium
limestone mine in the province of Shanxi, China. HKMH is in the
process of restarting operations.
The increase in shareholding in HKMH is the result of the
completion of the enforcement of a share pledge in favour of
Dynamite Win Limited by Superior Profit International Investment
Limited ("Superior Profit"), the previous controlling shareholder
of HKMH, following the suspension of HKMH's IPO process as
announced in January 2016.
Mine operations are scheduled to restart during the second half
of 2018 and it is anticipated that HKMH will seek an admission to
the Hong Kong Stock Exchange at an appropriate time once full
operations and sales have been fully established.
Meize Energy Industries Holdings Limited ("Meize") Meize is a
privately-owned company that designs and manufactures blades for
wind turbines. It has a strong order book and its financial
performance has been in line with expectations. Negotiations
regarding the partial sale and restructuring of this investment are
continuing and we hope to be able to update the market on this in
due course.
Administrative expenses increased from US$1.9 million to US$8.0
million principally as a result of an incentive fee of US$3.5
million payable to the Investment Manager and the award of warrants
under the ownership-based compensation scheme for senior management
and the equity compensation scheme for the Investment Manager to
the directors and the Investment Manager with an aggregate fair
value of US$2.3 million.
Quarterly NAV Updates
Due to the significant increase in ADAM's percentage holding in
HKMH during the year and its potential impact on the NAV, in
February 2018 the Board determined not to publish an estimated NAV
per share prior to completion of the audit for the year ended 31
December 2017. In future, the Board plans to resume publishing an
estimated NAV per share following each quarter end.
John Croft
Chairman of the Board
21 June 2018
Consolidated Statement of Comprehensive Income
For the year ended 31 December 2017
2017 2016
US$'000 US$'000
Realised (loss)/gain on disposal
of investments (14,329) 5
Fair value changes on financial assets
at fair value through profit or loss 33,885 (34,094)
Loan written off - (2,238)
Administrative expenses (7,958) (1,948)
----------- -----------
Operating gain/(loss) 11,598 (38,275)
Finance income 82 80
Finance expense - (98)
Dividend income - 911
Other income 14 220
----------- -----------
Profit/(Loss) before taxation 11,694 (37,162)
Taxation - -
----------- -----------
Profit/(Loss) for the year 11,694 (37,162)
Other comprehensive income:
Items that will or may be reclassified
to profit or loss:
Exchange differences arising on translation - -
of foreign operations
------- -----------
Total comprehensive income/(expense)
for the year 11,694 (37,162)
=========== ===========
Profit/(Loss) per share
Basic 15.23 (48.40)
cents cents
Diluted 14.96 (48.40)
cents cents
The results reflected above relate to continuing operations.
Consolidated Statement of Changes in Equity
For the year ended 31 December 2017
Share capital Share based payment reserve Accumulated losses Total
US$'000 US$'000 US$'000 US$'000
Group balance at 1 January 2016 129,543 1 (14,592) 114,952
Loss for the year - - (37,162) (37,162)
Other comprehensive income
Exchange differences arising on
translation of foreign
operations - - - -
Total comprehensive expense for
the year - - (37,162) (37,162)
Issue of shares - - - -
-------------- ---------------------------- ------------------- ---------
Share-based payments - (1) - (1)
-------------- ---------------------------- ------------------- ---------
Group balance at 31 December
2016 and 1 January 2017 129,543 - (51,754) 77,789
Profit for the year - - 11,694 11,694
Other comprehensive income
Exchange differences arising on - - - -
translation of foreign
operations
Total comprehensive income for
the year - - 11,694 11,694
Issue of shares - - - -
Share-based payments - 4,070 - 4,070
-------------- ---------------------------- ------------------- ---------
Group balance at 31 December
2017 129,543 4,070 (40,060) 93,553
-------------- ---------------------------- ------------------- ---------
Consolidated Statement of Financial Position
As at 31 December 2017
2017 2016
US$'000 US$'000
Assets
Unquoted financial assets
at fair value through profit
or loss 75,639 75,044
Loans and other receivables 6,579 1,514
Cash and cash equivalents 13,217 1,308
--------- ------------
Total assets 95,435 77,866
--------- ------------
Liabilities
Loan payables and interest - -
payables
Other payables and accruals 1,882 77
--------- ------------
Total liabilities 1,882 77
--------- ------------
Net assets 93,553 77,789
========= ============
Equity and reserves
Share capital 129,543 129,543
Share based payment reserve 4,070 -
Accumulated losses (40,060) (51,754)
--------- ------------
Total equity and reserves
attributable to owners of
the parent 93,553 77,789
========= ============
The financial statements were approved by the Board of Directors
and authorised for issue on
21 June 2018 and signed on its behalf by:
John Croft
Director
Consolidated Cash Flow Statement
For the year ended 31 December 2017
2017 2016
US$'000 US$'000
Cash flows from operating activities
Gain/(Loss) before taxation 11,694 (37,162)
Adjustments for:
Dividend income - (911)
Finance income (82) (80)
Finance expense - 98
Exchange gain (453) -
Loan written off - 2,238
Fair value changes on unquoted financial
assets at fair value through profit or loss (33,885) 34,094
Realised loss/(gain) on disposal of investments 14,329 (5)
Share-based expenses 4,070 (1)
Decrease/(Increase) in other receivables (139) (12)
Increase/(Decrease) in other payables and
accruals 1,805 (186)
--------- ---------
Net cash used in operating activities (2,661) (1,927)
--------- ---------
Cash flows from investing activities
Dividend income received - 1,611
Sale proceeds of unquoted financial assets
at fair value through profit or loss 15,100 756
Purchase of unquoted financial assets at
fair value through profit or loss - (2,560)
Loans granted (530) -
Proceeds from repayment of loan granted - 2,400
--------- ---------
Net cash generated in investing activities 14,570 2,207
--------- ---------
Cash flows from financing activities
Finance expense paid - (216)
Loans repayment - (2,400)
Net proceeds from issue of shares - -
Net cash used from financing activities - (2,616)
--------- ---------
Net increase / (decrease) in cash and cash
equivalents 11,909 (2,336)
Cash and cash equivalents and net debt at
the beginning of the year 1,308 3,644
Cash and cash equivalents and net debt at
the end of the year 13,217 1,308
========= =========
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FR PGUWAQUPRPGU
(END) Dow Jones Newswires
June 21, 2018 02:00 ET (06:00 GMT)
Jade Road Investments (LSE:JADE)
Historical Stock Chart
From Apr 2024 to May 2024
Jade Road Investments (LSE:JADE)
Historical Stock Chart
From May 2023 to May 2024